Optical Coherence Tomography Angiographic Evaluation of Macular Vessel Density in Diabetic Macular Edema After Intravitreal Dexamethasone Implants: A Prospective Interventional Trial.

BACKGROUND AND OBJECTIVE The goal of this study was to assess macular vascular density evolution, macular thickness, and functional outcomes after intravitreal dexamethasone implants for diabetic macular edema. PATIENTS AND METHODS Vascular density was evaluated with optical coherence tomography (OCT) angiography in 21 eyes. Macular thickness was evaluated with structural OCT. Visual acuity and contrast sensitivity were evaluated before and after treatment, and these functional outcomes were analyzed for association with anatomic outcomes. Macular vessel density in the superficial capillary plexus was evaluated with OCT angiography and quantified in areas with no fluid, allowing a more accurate measurement and eliminating the segmentation bias in areas with intra-retinal fluid. Such a methodology was possible by positioning the scans only in areas with no fluid before and after the implant. The absence of fluid in these areas was confirmed by three experienced evaluators using both the B-scan and the en face. Visual acuity and contrast sensitivity were evaluated before and after treatment, and these functional outcomes were analyzed for association with anatomic outcomes. RESULTS At 30, 60, and 90 days after implantation, there was improvement in macular perfusion in areas without fluid after intravitreal dexamethasone implantation, accompanied by reduced macular thickness and improved visual acuity (P < .001). However, there was no improvement in contrast sensitivity after treatment. CONCLUSIONS Improved macular perfusion after treatment with intravitreal dexamethasone implantation may be associated with modulation of leukostasis, when the release of cytokines leads to capillary endothelial damage and obstruction of the micro-vasculature, leading to impaired capillary perfusion and ischemic damage. Despite the anatomical and functional findings demonstrated, further studies are needed to prove the relationship between the inflammatory mechanisms of diabetic macular edema and its relationship with macular perfusion and functional aspects. [Ophthalmic Surg Lasers Imaging Retina 2023;54(3):174-182.].

[1]  V. Kansal,et al.  Optical coherence tomography angiographic changes following loading phase with intravitreal aflibercept for diabetic macular edema. , 2022, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[2]  T. Wong,et al.  Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. , 2021, Ophthalmology.

[3]  M. Shimura,et al.  Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema , 2021, International journal of molecular sciences.

[4]  S. Nicoară,et al.  Optical Coherence Tomography (Angiography) Biomarkers in the Assessment and Monitoring of Diabetic Macular Edema , 2020, Journal of diabetes research.

[5]  J. Forrester,et al.  The Role of Inflammation in Diabetic Retinopathy , 2020, Frontiers in Immunology.

[6]  D. Sarraf,et al.  Macular microvascular changes after intravitreal bevacizumab injection in diabetic macular edema. , 2020, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[7]  S. Androudi,et al.  OCT Angiography Study of the Macula in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept , 2020, Ocular immunology and inflammation.

[8]  A. A. Kazak,et al.  Structural en face optical coherence tomography imaging for identification of leaky microaneurysms in diabetic macular edema , 2019, International Ophthalmology.

[9]  M. Parravano,et al.  One-year follow-up of ischemic index changes after intravitreal dexamethasone implant for diabetic macular edema: an ultra-widefield fluorescein angiography study , 2019, Acta Diabetologica.

[10]  S. Lee,et al.  Peripapillary microvasculature in patients with diabetes mellitus: An optical coherence tomography angiography study , 2019, Scientific Reports.

[11]  Daniel L. Chao,et al.  OCT Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema. , 2019, Ophthalmology. Retina.

[12]  J. Chhablani,et al.  Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results , 2019, Acta Diabetologica.

[13]  P. Nucci,et al.  Diabetic macular edema with neuroretinal detachment: OCT and OCT-angiography biomarkers of treatment response to anti-VEGF and steroids , 2019, Acta Diabetologica.

[14]  M. Maia,et al.  Microperimetry and OCT angiography evaluation of patients with ischemic diabetic macular edema treated with monthly intravitreal bevacizumab: a pilot study , 2019, International Journal of Retina and Vitreous.

[15]  Yoo-Ri Chung,et al.  Insights into the pathogenesis of cystoid macular edema: leukostasis and related cytokines. , 2019, International journal of ophthalmology.

[16]  C. Cheung,et al.  OCT Angiography Metrics Predict Progression of Diabetic Retinopathy and Development of Diabetic Macular Edema: A Prospective Study. , 2019, Ophthalmology.

[17]  J. Duker,et al.  Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy , 2019, International Ophthalmology.

[18]  Chris A. Johnson,et al.  Disorganization of Retinal Inner Layers (DRIL) and Neuroretinal Dysfunction in Early Diabetic Retinopathy , 2018, Investigative ophthalmology & visual science.

[19]  Yue Shi,et al.  Repeatability and Reproducibility of Superficial Macular Retinal Vessel Density Measurements Using Optical Coherence Tomography Angiography En Face Images , 2017, JAMA ophthalmology.

[20]  Junyeop Lee,et al.  Correlation between Deep Capillary Plexus Perfusion and Long-Term Photoreceptor Recovery after Diabetic Macular Edema Treatment. , 2017, Ophthalmology. Retina.

[21]  Francesco Bandello,et al.  Optical coherence tomography angiography analysis of retinal vascular plexuses and choriocapillaris in patients with type 1 diabetes without diabetic retinopathy , 2017, Acta Diabetologica.

[22]  Lei Liu,et al.  Quantifying Microvascular Abnormalities With Increasing Severity of Diabetic Retinopathy Using Optical Coherence Tomography Angiography , 2017, Investigative ophthalmology & visual science.

[23]  K. Tripathy,et al.  En Face Optical Coherence Tomography of Cystoid Macular Edema. , 2016, JAMA ophthalmology.

[24]  Junyeop Lee,et al.  Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response. , 2016, Ophthalmology.

[25]  E. Midena,et al.  Multimodal retinal imaging of diabetic macular edema: toward new paradigms of pathophysiology , 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.

[26]  Dawn A Sim,et al.  Predictive factors for the progression of diabetic macular ischemia. , 2013, American journal of ophthalmology.

[27]  S. Vujosevic,et al.  Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings. , 2006, Investigative ophthalmology & visual science.

[28]  Jennifer K. Sun,et al.  Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial , 2018, JAMA ophthalmology.

[29]  Galina Dimitrova,et al.  Quantitative Retinal Optical Coherence Tomography Angiography in Patients With Diabetes Without Diabetic Retinopathy. , 2017, Investigative ophthalmology & visual science.